Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Tax Provisions (2023)

Historic Tax Provisions for Foghorn Therapeutics (FHTX) over the last 1 years, with Q4 2023 value amounting to $2.0 million.

  • Foghorn Therapeutics' Tax Provisions changed N/A to $2.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was $2.0 million, marking a year-over-year decrease of 1133.93%. This contributed to the annual value of $4.2 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Foghorn Therapeutics reported Tax Provisions of $2.0 million as of Q4 2023.
  • Foghorn Therapeutics' 5-year Tax Provisions high stood at $2.0 million for Q4 2023, and its period low was $560000.0 during Q1 2023.